Getting the Most from DOAC Therapy: Minimizing Risk and Maximizing Adherence

Description

Boost your confidence in making clinical decisions for patients using direct oral anticoagulants (DOACs). It can be difficult to determine the appropriate dosage of these agents for individual patients, the safe use of these medications, and how to reverse overdoses. This interactive session will teach pharmacists about cutting-edge advances in anticoagulation therapy and how to manage challenges posed by DOACs.

Pharmacist Learning Objectives

At the completion of this knowledge-based activity, participants will be able to:

  1. Develop an evidence-based patient care plan for a patient requiring treatment with a direct oral anticoagulant (DOAC).
  2. Identify patients who are at high-risk for adverse events associated with DOAC therapy and identify strategies for managing these patients.
  3. List strategies for reversal of a DOAC overdose.
  4. Evaluate strategies that optimize adherence and persistence for patients receiving DOAC therapy.
 
 

Supporter

This activity is supported by an independent educational grant from Pfizer, Inc.

 
Speakers:
Stuart
Stuart Haines, PHARMD
Professor and Director, Pharmacy Professional Development
University of Mississippi School of Pharmacy
 
Brent
Brent Reed, PharmD
Associate Professor
University of Maryland School of Pharmacy
 
Learning Level: Level 2
Track: Pharmacist Clinical Patient Care Services, Ambulatory Care
Session Time Slot(s): 
Date: 
Saturday, March 23
Time: 
7:00 AM - 8:30 AM
Room: 
Washington State Convention Center - Room 608-609
ACPE Pharmacist: 0202-0000-19-034-L01-P
CEUs Pharmacist: .15
Activity Type:
Application-based